96 research outputs found
Exploring the ability of LARS2 carboxy-terminal domain in rescuing the MELAS phenotype
The m.3243A>G mutation within the mitochondrial mt-tRNALeu(UUR) gene is the most prevalent variant linked to mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome. This pathogenic mutation causes severe impairment of mitochondrial protein synthesis due to alterations of the mutated tRNA, such as reduced aminoacylation and a lack of post-transcriptional modification. In transmitochondrial cybrids, overexpression of human mitochondrial leucyl-tRNA synthetase (LARS2) has proven effective in rescuing the phenotype associated with m.3243A>G substitution. The rescuing activity resides in the carboxy-terminal domain (Cterm) of the enzyme; however, the precise molecular mechanisms underlying this process have not been fully elucidated. To deepen our knowledge on the rescuing mechanisms, we demonstrated the interactions of the Cterm with mutated mt-tRNALeu(UUR) and its precursor in MELAS cybrids. Further, the effect of Cterm expression on mitochondrial functions was evaluated. We found that Cterm ameliorates de novo mitochondrial protein synthesis, whilst it has no effect on mt-tRNALeu(UUR) steady-state levels and aminoacylation. Despite the complete recovery of cell viability and the increase in mitochondrial translation, Cterm-overexpressing cybrids were not able to recover bioenergetic competence. These data suggest that, in our MELAS cell model, the beneficial effect of Cterm may be mediated by factors that are independent of the mitochondrial bioenergetics
Three-dimensional structure of human cyclooxygenase (hCOX)-1
The beneficial effects of Cyclooxygenases (COX) inhibitors on human health have been known for thousands of years. Nevertheless, COXs, particularly COX-1, have been linked to a plethora of human diseases such as cancer, heart failure, neurological and neurodegenerative diseases only recently. COXs catalyze the first step in the biosynthesis of prostaglandins (PGs) and are among the most important mediators of inflammation. All published structural work on COX-1 deals with the ovine isoenzyme, which is easier to produce in milligram-quantities than the human enzyme and crystallizes readily. Here, we report the long-sought structure of the human cyclooxygenase-1 (hCOX-1) that we refined to an R/Rfree of 20.82/26.37, at 3.36 Å resolution. hCOX-1 structure provides a detailed picture of the enzyme active site and the residues crucial for inhibitor/substrate binding and catalytic activity. We compared hCOX-1 crystal structure with the ovine COX-1 and human COX-2 structures by using metrics based on Cartesian coordinates, backbone dihedral angles, and solvent accessibility coupled with multivariate methods. Differences and similarities among structures are discussed, with emphasis on the motifs responsible for the diversification of the various enzymes (primary structure, stability, catalytic activity, and specificity). The structure of hCOX-1 represents an essential step towards the development of new and more selective COX-1 inhibitors of enhanced therapeutic potential
Un sistema informativo integrato a supporto delle decisioni nella pianificazione e gestione della risorsa idrica a fini irrigui in agricoltura.
A modified method for the purification of active large enzymes using the glutathione S-transferase expression system
The glutathione S-transferase (GST) fusion protein system is widely used for high-level expression and
efficient purification of recombinant proteins from bacteria. However many GST-tagged proteins are
insoluble, and the existing procedures, which employ a mixture of detergents to solubilize the molecules,
frequently compromise their functional activity. A further limitation is that large proteins (>80 kDa) are
poorly isolated by the current methods and are contaminated by truncated forms. To overcome these
problems, we provide here an improved method for efficient purification of active large GST-tagged
enzymes such as the 180-kDa GST-fused mitochondrial RNA polymerase
Human mitochondrial transcription and replication proteins are regulated via differential pathways
Human mitochondrial transcription and replication proteins are regulated via differential pathways
THE MITOCHONDRIAL TRANSCRIPTION TERMINATION FACTOR MTDBP DISPLAYS A CONTRAHELICASE ACTIVITY
Nuclear Respiratory Factor 2 Induces the Expression of Many but Not All Human Proteins Acting in Mitochondrial DNA Transcription and Replication.
- …